Trexquant Investment’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,672
| Closed | -$213K | – | 1957 |
|
|
2022
Q2 | $213K | Sell |
6,672
-4,588
| -41% | -$146K | 0.01% | 1324 |
|
|
2022
Q1 | $390K | Sell |
11,260
-15,662
| -58% | -$542K | 0.02% | 885 |
|
|
2021
Q4 | $788K | Buy |
26,922
+18,779
| +231% | +$550K | 0.05% | 467 |
|
|
2021
Q3 | $207K | Buy |
+8,143
| New | +$207K | 0.02% | 949 |
|
|
2021
Q2 | – | Sell |
-7,947
| Closed | -$324K | – | 1637 |
|
|
2021
Q1 | $324K | Sell |
7,947
-7,496
| -49% | -$306K | 0.03% | 709 |
|
|
2020
Q4 | $669K | Buy |
15,443
+3,434
| +29% | +$149K | 0.07% | 358 |
|
|
2020
Q3 | $662K | Sell |
12,009
-1,586
| -12% | -$87.4K | 0.04% | 566 |
|
|
2020
Q2 | $858K | Buy |
13,595
+4,806
| +55% | +$303K | 0.06% | 447 |
|
|
2020
Q1 | $449K | Buy |
+8,789
| New | +$449K | 0.03% | 697 |
|
|
2019
Q2 | – | Sell |
-11,279
| Closed | -$597K | – | 1228 |
|
|
2019
Q1 | $597K | Buy |
+11,279
| New | +$597K | 0.04% | 539 |
|
|
2018
Q4 | – | Sell |
-34,966
| Closed | -$1.33M | – | 1391 |
|
|
2018
Q3 | $1.33M | Buy |
34,966
+30,540
| +690% | +$1.16M | 0.1% | 282 |
|
|
2018
Q2 | $200K | Sell |
4,426
-26,759
| -86% | -$1.21M | 0.01% | 792 |
|
|
2018
Q1 | $1.51M | Buy |
+31,185
| New | +$1.51M | 0.11% | 310 |
|
|
2017
Q4 | – | Sell |
-6,518
| Closed | -$202K | – | 1310 |
|
|
2017
Q3 | $202K | Buy |
+6,518
| New | +$202K | 0.05% | 640 |
|